Stathmin 2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{infobox .infobox-protein
| protein = Stathmin-2 (SCG10)
| gene = STMN2
| uniprot = P17516
| pdb = 1CK4
| mw = 20 kDa
| location = Cytoplasm, axons
| family = Stathmin family
}}
STMN2 PROTEIN is a gene/protein encoding a key neuronal protein involved in synaptic function, signal transduction, and cellular homeostasis. Dysfunction of STMN2 PROTEIN is associated with neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and related disorders.
Stathmin-2 (also known as SCG10 - Superior Cervical Ganglion 10) is a neuron-specific microtubule-destabilizing protein. It is a member of the stathmin family of phosphoproteins.
- N-terminal domain: Regulatory region with multiple phosphorylation sites
- Stathmin-like domain: Binds tubulin heterodimers
- C-terminal domain: Interaction domains
STMN2 is a potent microtubule-destabilizing protein:
- Binds to α/β-tubulin heterodimers, preventing polymerization
- Promotes microtubule depolymerization
- Regulates microtubule stability in axons
- Axonal growth: Promotes axonal extension during development
- Neuronal plasticity: Regulates microtubule dynamics in response to signals
- Regeneration: Upregulated after nerve injury
- Signal transduction: Phosphorylated by multiple kinases
Stathmin-2 is expressed in:
- Developing neurons (high expression)
- Adult neurons (lower expression)
- Peripheral nervous system
- Sympathetic neurons
- ALS: STMN2 is downregulated in motor neuron disease; loss correlates with axonal degeneration
- Charcot-Marie-Tooth disease: Altered microtubule dynamics contribute to neuropathy
- Peripheral neuropathy: Important for axonal regeneration
- Spinal cord injury: STMN2 promotes regeneration
- Not applicable (neuron-specific)
- Microtubule stabilization: Small molecules to stabilize microtubules
- Gene therapy: AAV-mediated STMN2 delivery for regeneration
- Understanding STMN2 downregulation in ALS
- Developing regenerative therapies for neuropathies
- {{cite journal | doi=10.1016/j.tins.2018.05.006 | title=Stathmin-2 in neurodegeneration }}
- {{cite journal | doi=10.1093/brain/awy004 | title=STMN2 and ALS }}
- {{cite journal | doi=10.1016/j.neuro.2018.09.012 | title=Axonal regeneration and STMN2 }}
The study of Stathmin 2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- {{cite journal | doi=10.1007/s00018-000-0000 | title=Proteasome function in neurodegeneration }}